J. Basu et al., ALTERATIONS IN ERYTHROCYTE GLUTATHIONE METABOLISM ASSOCIATED WITH CERVICAL DYSPLASIAS AND CARCINOMA IN-SITU, Cancer investigation, 11(6), 1993, pp. 652-659
The study was designed to test the hypothesis whether cervical dysplas
ias of the more severe grades are associated with elevated erythrocyte
glutathione levels. Subjects were women who obtained Pap tests and we
re subsequently found (1) not to have any cervical lesions or (2) to h
ave colposcopically visualized, biopsy-confirmed cervical abnormalitie
s histopathologically diagnosed as mild, moderate, severe dysplasias,
or carcinoma in situ (CIS). The erythrocyte levels of reduced glutathi
one (GSH), oxidized glutathione (GSSG), glutathione reductase (GR), gl
ucose-6-phosphate dehydrogenase (G6PD), and 6-phosphogluconate dehydro
genase (6PGD) were analyzed from coded peripheral venous blood samples
. GSH and GR concentrations increased with increasing severity of dysp
lasia. Exploratory data analysis and multiple pairwise comparisons sug
gested comparable levels of the glutathione-related variables between
these histopathological pairs: (1) mild and moderate dysplasias or (2)
severe dysplasia and CIS. We suggest that the changes in erythrocyte
glutathione-related indices in conjunction with histopathological diag
nosis may have the potential to distinguish between low- and high-grad
e cervical dysplastic lesions.